These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 31736768)

  • 1. Mineralocorticoid Receptor Signaling Contributes to Normal Muscle Repair After Acute Injury.
    Hauck JS; Howard ZM; Lowe J; Rastogi N; Pico MG; Swager SA; Petrosino JM; Gomez-Sanchez CE; Gomez-Sanchez EP; Accornero F; Rafael-Fortney JA
    Front Physiol; 2019; 10():1324. PubMed ID: 31736768
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myeloid mineralocorticoid receptors contribute to skeletal muscle repair in muscular dystrophy and acute muscle injury.
    Howard ZM; Rastogi N; Lowe J; Hauck JS; Ingale P; Gomatam C; Gomez-Sanchez CE; Gomez-Sanchez EP; Bansal SS; Rafael-Fortney JA
    Am J Physiol Cell Physiol; 2022 Mar; 322(3):C354-C369. PubMed ID: 35044859
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mineralocorticoid receptor antagonists improve membrane integrity independent of muscle force in muscular dystrophy.
    Hauck JS; Lowe J; Rastogi N; McElhanon KE; Petrosino JM; Peczkowski KK; Chadwick AN; Zins JG; Accornero F; Janssen PML; Weisleder NL; Rafael-Fortney JA
    Hum Mol Genet; 2019 Jun; 28(12):2030-2045. PubMed ID: 30759207
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mineralocorticoid Receptor Signaling in the Inflammatory Skeletal Muscle Microenvironments of Muscular Dystrophy and Acute Injury.
    Howard ZM; Gomatam CK; Piepho AB; Rafael-Fortney JA
    Front Pharmacol; 2022; 13():942660. PubMed ID: 35837290
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myeloid cells are capable of synthesizing aldosterone to exacerbate damage in muscular dystrophy.
    Chadwick JA; Swager SA; Lowe J; Welc SS; Tidball JG; Gomez-Sanchez CE; Gomez-Sanchez EP; Rafael-Fortney JA
    Hum Mol Genet; 2016 Dec; 25(23):5167-5177. PubMed ID: 27798095
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene expression effects of glucocorticoid and mineralocorticoid receptor agonists and antagonists on normal human skeletal muscle.
    Chadwick JA; Hauck JS; Gomez-Sanchez CE; Gomez-Sanchez EP; Rafael-Fortney JA
    Physiol Genomics; 2017 Jun; 49(6):277-286. PubMed ID: 28432191
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cell-type specific effects of mineralocorticoid receptor gene expression suggest intercellular communication regulating fibrosis in skeletal muscle disease.
    Gomatam CK; Ingale P; Rodriguez G; Munger S; Pomeranets R; Krishna S; Lowe J; Howard ZM; Rafael-Fortney JA
    Front Physiol; 2024; 15():1322729. PubMed ID: 38737833
    [No Abstract]   [Full Text] [Related]  

  • 8. Mineralocorticoid receptors are present in skeletal muscle and represent a potential therapeutic target.
    Chadwick JA; Hauck JS; Lowe J; Shaw JJ; Guttridge DC; Gomez-Sanchez CE; Gomez-Sanchez EP; Rafael-Fortney JA
    FASEB J; 2015 Nov; 29(11):4544-54. PubMed ID: 26178166
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Similar efficacy from specific and non-specific mineralocorticoid receptor antagonist treatment of muscular dystrophy mice.
    Lowe J; Floyd KT; Rastogi N; Schultz EJ; Chadwick JA; Swager SA; Zins JG; Kadakia FK; Smart S; Gomez-Sanchez EP; Gomez-Sanchez CE; Raman SV; Janssen PM; Rafael-Fortney JA
    J Neuromuscul Dis; 2016; 3(3):395-404. PubMed ID: 27822449
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renin-angiotensin-aldosterone system inhibitors improve membrane stability and change gene-expression profiles in dystrophic skeletal muscles.
    Chadwick JA; Bhattacharya S; Lowe J; Weisleder N; Rafael-Fortney JA
    Am J Physiol Cell Physiol; 2017 Feb; 312(2):C155-C168. PubMed ID: 27881412
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aldosterone promotes vascular remodeling by direct effects on smooth muscle cell mineralocorticoid receptors.
    Pruthi D; McCurley A; Aronovitz M; Galayda C; Karumanchi SA; Jaffe IZ
    Arterioscler Thromb Vasc Biol; 2014 Feb; 34(2):355-64. PubMed ID: 24311380
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic alcohol ingestion delays skeletal muscle regeneration following injury.
    Dekeyser GJ; Clary CR; Otis JS
    Regen Med Res; 2013 Dec; 1(1):2. PubMed ID: 25984321
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mineralocorticoid Receptor Antagonists in Muscular Dystrophy Mice During Aging and Exercise.
    Lowe J; Kadakia FK; Zins JG; Haupt M; Peczkowski KK; Rastogi N; Floyd KT; Gomez-Sanchez EP; Gomez-Sanchez CE; Elnakish MT; Rafael-Fortney JA; Janssen PML
    J Neuromuscul Dis; 2018; 5(3):295-306. PubMed ID: 30010143
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Small molecule nicotinamide N-methyltransferase inhibitor activates senescent muscle stem cells and improves regenerative capacity of aged skeletal muscle.
    Neelakantan H; Brightwell CR; Graber TG; Maroto R; Wang HL; McHardy SF; Papaconstantinou J; Fry CS; Watowich SJ
    Biochem Pharmacol; 2019 May; 163():481-492. PubMed ID: 30753815
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decrease of myofiber branching via muscle-specific expression of the olfactory receptor mOR23 in dystrophic muscle leads to protection against mechanical stress.
    Pichavant C; Burkholder TJ; Pavlath GK
    Skelet Muscle; 2016; 6():2. PubMed ID: 26798450
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mineralocorticoid receptor antagonists and glucocorticoids differentially affect skeletal muscle inflammation and pathology in muscular dystrophy.
    Howard ZM; Gomatam CK; Rabolli CP; Lowe J; Piepho AB; Bansal SS; Accornero F; Rafael-Fortney JA
    JCI Insight; 2022 Oct; 7(19):. PubMed ID: 36040807
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The mineralocorticoid receptor promotes fibrotic remodeling in atrial fibrillation.
    Lavall D; Selzer C; Schuster P; Lenski M; Adam O; Schäfers HJ; Böhm M; Laufs U
    J Biol Chem; 2014 Mar; 289(10):6656-6668. PubMed ID: 24469458
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aldosterone deficiency and mineralocorticoid receptor antagonism prevent angiotensin II-induced cardiac, renal, and vascular injury.
    Luther JM; Luo P; Wang Z; Cohen SE; Kim HS; Fogo AB; Brown NJ
    Kidney Int; 2012 Sep; 82(6):643-51. PubMed ID: 22622494
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Macrophage mineralocorticoid receptor signaling plays a key role in aldosterone-independent cardiac fibrosis.
    Bienvenu LA; Morgan J; Rickard AJ; Tesch GH; Cranston GA; Fletcher EK; Delbridge LM; Young MJ
    Endocrinology; 2012 Jul; 153(7):3416-25. PubMed ID: 22653557
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Finerenone Impedes Aldosterone-dependent Nuclear Import of the Mineralocorticoid Receptor and Prevents Genomic Recruitment of Steroid Receptor Coactivator-1.
    Amazit L; Le Billan F; Kolkhof P; Lamribet K; Viengchareun S; Fay MR; Khan JA; Hillisch A; Lombès M; Rafestin-Oblin ME; Fagart J
    J Biol Chem; 2015 Sep; 290(36):21876-89. PubMed ID: 26203193
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.